Antagonistic Glucagon Receptor Antibody Promotes α-Cell Proliferation and Increases β-Cell Mass in Diabetic Mice
Summary: Under extreme conditions or by genetic modification, pancreatic α-cells can regenerate and be converted into β-cells. This regeneration holds substantial promise for cell replacement therapy in diabetic patients. The discovery of clinical therapeutic strategies to promote β-cell regeneratio...
Main Authors: | Rui Wei, Liangbiao Gu, Jin Yang, Kun Yang, Junling Liu, Yunyi Le, Shan Lang, Haining Wang, Dung Thai, Hai Yan, Tianpei Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | iScience |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004219301671 |
Similar Items
-
Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes
by: Shan Lang, et al.
Published: (2020-04-01) -
Pro-α-cell-derived β-cells contribute to β-cell neogenesis induced by antagonistic glucagon receptor antibody in type 2 diabetic mice
by: Xiaona Cui, et al.
Published: (2022-07-01) -
Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose outputResearch in context
by: Junling Liu, et al.
Published: (2019-03-01) -
Insulin and glucagon regulate pancreatic α-cell proliferation.
by: Zhuo Liu, et al.
Published: (2011-01-01) -
Glucagon secretion from pancreatic α-cells
by: Briant, L, et al.
Published: (2016)